Search results
Results from the WOW.Com Content Network
Tonix Pharmaceuticals (Tonix Pharmaceuticals Holding Corp.) is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
On Monday, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) was awarded an Other Transaction Agreement (OTA) with a potential value of up to $34 million over five years by the Defense Threat ...
CHATHAM, N.J., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced financial results for the second quarter ended June 30, 2024, and provided an overview of recent ...
On Monday, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) and Bilthoven Biologicals collaborated to advance TNX-801, Tonix’s mpox vaccine candidate. Bilthoven Biologicals is part of the world ...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are soaring Monday after the World Health Organization (WHO) declared monkeypox a public health emergency of global concern. Tonix's TNX ...
CHATHAM, N.J., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, and Bilthoven Biologicals (BBio), part of the world’s largest vaccine manufacturer the Cyrus Poonawalla Group, which includes ...
A Form 4 filing filed with the SEC on Thursday, March 25 showed that Lederman Seth bought 16,733 shares of Tonix Pharmaceuticals Inc (NASDAQ:TNXP) at an average price of $1.32. The transaction ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.